3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
1
Breast
1
Conditions
Hematologic Neoplasms
4
Breast Neoplasms
4
Lung Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic Neoplasms
2
Hodgkin Disease
2
Gastrointestinal Diseases
2
Carcinoma, Non-Small-Cell Lung
2
Trastuzumab Cardiotoxicity
1
Small Cell Lung Carcinoma
1
Sarcopenia
1
Radiation Pneumonitis
1
Radiation Fibrosis Syndrome
1
Pelvic Neoplasms
1
Oropharyngeal Neoplasms
1
Obesity
1
Neoplasms
1
Myocardial Fibrosis
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Multiple Endocrine Neoplasia Type 1
1
Malignant Primary Pelvic Neoplasm
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Acute
1
Hereditary Breast and Ovarian Cancer Syndrome
1
Heart Diseases
1
Heart Defects, Congenital
1
Esophageal Neoplasms
1
Dyslipidemias
1
Colorectal Neoplasms
1
Interventions
Surveys and Questionnaires
3
Blood Specimen Collection
2
Surgical Procedures, Operative
1
Hysterectomy
1
High-Throughput Nucleotide Sequencing
1
Exercise Test
1
Echocardiography
1
CA-125 Antigen
1
Buthionine Sulfoximine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Hereditary Breast and Ovarian Cancer Syndrome
×
Exercise Test
×
Clear all
NCT03510689
2024-10-16
Gene-HEART
Abramson Cancer Center at Penn Medicine
Completed
79 enrolled